Barriers to Adherence to Recommended Follow-up in Women With a History of Gestational Diabetes
NCT ID: NCT01681147
Last Updated: 2023-05-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2012-06-30
2018-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Prevention Strategies in Women With Gestational Diabetes Mellitus (GDM)
NCT01344278
Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia
NCT07141173
The Effect of Early Nutrition Intervention on the Incidence of High-risk Patients With Gestational Diabetes
NCT03550976
Lifestyle Intervention Program for Women With Gestational Diabetes or Gestational Impaired Glucose Tolerance
NCT01489163
Healthy Eating in Women at Risk of Gestational Diabetes
NCT05299502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will participate in an online nutrition and physical activity class from 6 weeks to 3 months and 9 months for women assigned to both groups 2 and 3. For those women assigned to group 3, they will also do block testing using an assigned blood glucose meter and test strips 4 times a day for 4 consecutive days each month, starting at 3 months and ending at 9 months. Women will have the option of submitting meter blood glucose data via e-mailed logs or downloading directly to the clinic using Diasend software. Once downloaded, the Diasend software will create a PDF document with all recorded blood glucose values.
For purposes of this study, we will obtain a Diasend account specific to this study, which will allow women to download blood glucose information with an anonymous unique identifier that can be accessed by the study's Principal Investigator and the Collaborative Institutional Training Initiative (CITI)-certified, International Review Board (IRB)-approved research assistant. Upon accessing the PDF document with the blood glucose meter information, both the PI and the Research Assistant can link blood glucose data with questionnaire and other health information collected in this study through the unique identifiers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
Standard postpartum care after a pregnancy with gestational diabetes
No interventions assigned to this group
Standard Care+Education Classes
Standard postpartum care after a pregnancy with gestational diabetes
2 online nutrition and exercise education classes
2 online nutrition and exercise education classes
Two online nutrition and physical activity classes will accessed from a computer, android phone or a tablet. Each class is estimated to last about 1.5- 2 hours and will be accessed 6 weeks-3 months and 9 months
Standard Care+Education Classes+Glucose Monitoring
Standard postpartum care after a pregnancy with gestational diabetes
2 online nutrition and exercise education classes
Self monitoring of blood glucose levels
2 online nutrition and exercise education classes
Two online nutrition and physical activity classes will accessed from a computer, android phone or a tablet. Each class is estimated to last about 1.5- 2 hours and will be accessed 6 weeks-3 months and 9 months
Self monitoring of blood glucose levels
Self monitoring of blood glucose levels four times a day for four consecutive days once a month from 6 weeks-3 months through 9 months post partum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2 online nutrition and exercise education classes
Two online nutrition and physical activity classes will accessed from a computer, android phone or a tablet. Each class is estimated to last about 1.5- 2 hours and will be accessed 6 weeks-3 months and 9 months
Self monitoring of blood glucose levels
Self monitoring of blood glucose levels four times a day for four consecutive days once a month from 6 weeks-3 months through 9 months post partum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 21 and 45 years
* Preconception BMI 19-40
* Seen for at least 2 visits in the Diabetes in Pregnancy Program during their pregnancy
* Singleton pregnancy
Exclusion Criteria
* BMI \>40
* Multiple gestation (i.e., twins, triplets, etc.)
21 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roche Diagnostics GmbH
INDUSTRY
Joslin Diabetes Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florence Brown, MD
Role: PRINCIPAL_INVESTIGATOR
Joslin Diabetes Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joslin Diabetes Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHS 2012-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.